Cullinan Therapeutics To Participate In Upcoming Investor Conferences
(MENAFN- GlobeNewsWire - Nasdaq) CAMBRIDGE, Mass., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc.
- Nadim Ahmed, Chief Executive Officer, and Jeffrey Jones, M.D., M.B.A., Chief Medical Officer, will participate in a fireside chat at the Stifel 2026 Healthcare Conference in New York, NY on Tuesday, November 10, 2026, at 2:40 p.m. ET. Nadim Ahmed, Chief Executive Officer, and Jeffrey Jones, M.D., M.B.A., Chief Medical Officer, will participate in a fireside chat at the UBS Global Biopharma Conference 2026 in London, UK on Tuesday, November 17, 2026, at 2:00 p.m. GMT (9:00 a.m. ET).
About Cullinan Therapeutics
Cullinan Therapeutics, Inc. LinkedIn XContacts:
Investors
Nick Smith
+1 401.241.3516
...
Media
Rose Weldon
+1 215.801.7644
...
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.
Comments
No comment